Moat
9.0/10
Large installed bases, recurring instruments and accessories revenue, regulatory complexity, clinical training, and workflow integration create high switching costs.
ISRGQueued from the May 25, 2026 S&P 500 market-cap snapshot ranks 51-75.
Intuitive Surgical
Intuitive Surgical develops, manufactures, and markets robotic-assisted surgical systems, instruments, accessories, software, and services for minimally invasive care.
Metadata
Where this company sits
- Ticker
- ISRG
- Rank snapshot
- ≈ 65
- Sector
- Health Care
- Industry
- Pharma & MedTech
- Region
- United States
- Index
- S&P 500 · Top 75 by market cap
Metrics
Scoring view
Every metric is paired with a short rationale. The numbers are deliberate, not divine.
Decentralizability
2.0/10
Clinical surgical robotics requires regulated hardware, validated instruments, trained surgeons, hospital procurement, and liability-bearing service infrastructure, so open alternatives are mostly research-stage today.
Profitability
8.0/10
The company reported 2025 revenue of $10.1 billion, operating income of $2.95 billion, and gross profit equal to 66.0% of revenue.
Price / Earnings
53.2x
StockAnalysis reported a trailing PE ratio of 53.24 for ISRG.
Market cap
$155.2B
StockAnalysis reported Intuitive Surgical's market capitalization as $155.16 billion as of May 22, 2026.
Freed-up capital potential
$7.4B
Derived from market cap, moat resistance, decentralizability, and profitability. It is a directional estimate of value capture that could come under pressure if open alternatives compound.
Narrative
Why the company matters
A short editorial overview plus the current thesis on moat strength and decentralization pressure.
Robotic surgery platform company
Intuitive Surgical's core business is built around the da Vinci surgical system, a robotic-assisted platform used across general surgery, urology, gynecology, cardiothoracic, and head and neck procedures.
The company also sells the Ion endoluminal system, a flexible robotic catheter platform first cleared for minimally invasive lung biopsy procedures.
Installed-base economics
The company combines capital equipment placements with recurring instruments, accessories, services, software, and training. In 2025 it reported about 11,106 installed da Vinci systems and about 995 installed Ion systems.
That installed base matters because each procedure drives demand for instruments and accessories, while hospitals also depend on service, training, workflow integration, and regulatory support.
Moat reading
Intuitive's moat is unusually strong for medical hardware because it combines regulated devices, clinical training, surgeon familiarity, procedure workflow, hospital capital budgeting, service contracts, and a large installed base. In 2025 the company reported roughly 3.15 million da Vinci procedures, 144,100 Ion procedures, and $6.02 billion of instruments and accessories revenue.
The business is not just a robot sale. It is an operating-room ecosystem with consoles, carts, imaging, instruments, accessories, training, service, data products, and regulatory documentation. That makes replacement slow even when competing technologies exist.
Decentralization reading
Intuitive is difficult to decentralize in the near term because surgical robotics is safety-critical, regulated, capital intensive, and deeply tied to hospital credentialing and liability. Open hardware and open robotics research platforms can pressure the research and training layers before they threaten clinical deployment.
The more plausible decentralization path is not a near-term open-source da Vinci clone. It is a layered shift in which universities, hospitals, simulation labs, cooperative manufacturers, and regulators standardize open interfaces, validated training environments, serviceable components, and auditable safety cases.
Products
Where the moat actually touches users
These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 2 structured disruption concepts across the current product set.
2 disruption concepts tracked0 documented exceptions
da Vinci
Robotic-assisted surgical system
1 conceptda Vinci is Intuitive Surgical's flagship robotic-assisted surgical system for minimally invasive procedures across multiple soft-tissue specialties.
Ion
Robotic-assisted endoluminal bronchoscopy system
1 conceptIon is Intuitive Surgical's flexible robotic-assisted catheter platform for minimally invasive lung biopsy procedures.
Technology waves
Strategic lenses
These are the repo's explicit bias terms: the technologies expected to keep making incumbents less inevitable over time.
Printed electronics and PCB tooling
PCB fabrication, chip packaging, and increasingly automated electronics assembly continue shrinking the distance between prototype and local production.
- • Incumbents with hardware lock-in should be evaluated against a future of much cheaper custom electronics.
- • Pick-and-place automation lowers the coordination cost for distributed manufacturing cells.
- • The most durable hardware moats may migrate toward fabs, ecosystems, and compliance rather than assembly itself.
Microfactories and automated mini-home production
Small, software-defined manufacturing cells could make localized production less eccentric and more default.
- • Products with heavy branding but generic bill-of-materials profiles look increasingly vulnerable.
- • Logistics moats still matter, but their margin for arrogance should narrow.
- • Open-source production recipes can pressure both price and product differentiation.
Paper trail
Visible evidence trail
These sources shaped the scoring and writing. The site is opinionated, but it should not behave like it is improvising facts in a dark room.
Intuitive Surgical 2025 Form 10-K
U.S. Securities and Exchange Commission · regulatory filing
Primary filing for Intuitive's business description, 2025 revenue, installed base, procedure volume, Ion description, and profitability.
Reviewed 2026-05-25
Intuitive Products and Services
Intuitive Surgical · product page
Official product overview for da Vinci, Ion, and Intuitive's connected product ecosystem.
Reviewed 2026-05-25
Intuitive Surgical Market Cap
StockAnalysis · market data
Market capitalization reference used for the current market-cap metric.
Reviewed 2026-05-25
Intuitive Surgical Statistics
StockAnalysis · market data
Valuation and profitability reference for PE ratio, margins, revenue, and net income.
Reviewed 2026-05-25